Towards depersonalized abacavir therapy: chemical modification eliminates HLA-B*57 : 01-restricted CD8+ T-cell activation. (2015)

First Author: Naisbitt DJ
Attributed to:  UoLiverpool Confidence in Concept 2013 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/qad.0000000000000867

PubMed Identifier: 26372480

Publication URI: http://europepmc.org/abstract/MED/26372480

Type: Journal Article/Review

Volume: 29

Parent Publication: AIDS (London, England)

Issue: 18

ISSN: 0269-9370